Profusa regains compliance with Nasdaq listing requirements
Profusa Inc., a digital health company based in Berkeley, California, has regained compliance with Nasdaq's minimum publicly held shares requirement, according to a press release. The company received notification from Nasdaq on August 14, following the effectiveness of its 1-for-4 reverse stock split, indicating it had fewer than 500,000 publicly held shares required under Nasdaq Listing Rule 5550(a)(4).
Nasdaq's review of Profusa's compliance closed on August 21, and the exchange determined the company now meets the rule. The notice has no impact on the listing or trading of Profusa's securities, which continue to be traded on The Nasdaq Capital Market under the symbol PFSA. Profusa develops tissue-integrated sensors for personal and medical use.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
